These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29281185)

  • 1. Hepatitis C virus: Enslavement of host factors.
    Sharma G; Raheja H; Das S
    IUBMB Life; 2018 Jan; 70(1):41-49. PubMed ID: 29281185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection.
    Wong MT; Chen SS
    Cell Mol Immunol; 2016 Jan; 13(1):11-35. PubMed ID: 25544499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection.
    Yamashita T; Honda M; Kaneko S
    J Gastroenterol Hepatol; 2011 Jun; 26(6):960-4. PubMed ID: 21443660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
    Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
    J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers.
    Ishibashi M; Yamaguchi H; Hirotani Y; Sakurada A; Endo T; Sugitani M; Takayama T; Makishima M; Esumi M
    Arch Virol; 2018 Apr; 163(4):855-865. PubMed ID: 29248968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.
    Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF
    J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult hepatitis C virus infection: a new form of hepatitis C.
    Carreño V
    World J Gastroenterol; 2006 Nov; 12(43):6922-5. PubMed ID: 17109511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput approaches to unravel hepatitis C virus-host interactions.
    Colpitts CC; El-Saghire H; Pochet N; Schuster C; Baumert TF
    Virus Res; 2016 Jun; 218():18-24. PubMed ID: 26410623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex lipid metabolic remodeling is required for efficient hepatitis C virus replication.
    Hofmann S; Krajewski M; Scherer C; Scholz V; Mordhorst V; Truschow P; Schöbel A; Reimer R; Schwudke D; Herker E
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1041-1056. PubMed ID: 29885363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene.
    El-Shamy A; Eng FJ; Doyle EH; Klepper AL; Sun X; Sangiovanni A; Iavarone M; Colombo M; Schwartz RE; Hoshida Y; Branch AD
    J Hepatol; 2015 Dec; 63(6):1323-33. PubMed ID: 26220749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual hepatitis C virus in peripheral blood mononuclear cell as a risk factor for hepatocellular carcinoma after achieving a sustained virological response: a dogma or fiction.
    Hanafy AS; Seleem WM; Basha MAA; Marei AM
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1275-1282. PubMed ID: 31149912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis C?
    Michielsen P; Ho E; Francque S
    Minerva Gastroenterol Dietol; 2012 Mar; 58(1):65-79. PubMed ID: 22419005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C-associated liver carcinogenesis: role of PML nuclear bodies.
    Herzer K; Gerken G; Hofmann TG
    World J Gastroenterol; 2014 Sep; 20(35):12367-71. PubMed ID: 25253937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatiotemporal Coupling of the Hepatitis C Virus Replication Cycle by Creating a Lipid Droplet- Proximal Membranous Replication Compartment.
    Lee JY; Cortese M; Haselmann U; Tabata K; Romero-Brey I; Funaya C; Schieber NL; Qiang Y; Bartenschlager M; Kallis S; Ritter C; Rohr K; Schwab Y; Ruggieri A; Bartenschlager R
    Cell Rep; 2019 Jun; 27(12):3602-3617.e5. PubMed ID: 31216478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral hepatitis and liver cancer: the case of hepatitis C.
    Levrero M
    Oncogene; 2006 Jun; 25(27):3834-47. PubMed ID: 16799625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-155 and microRNA-196b: promising biomarkers in hepatitis C virus infection?
    Kałużna EM
    Rev Med Virol; 2014 May; 24(3):169-85. PubMed ID: 24591085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
    Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
    Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation of hepatitis C virus load, hypervariable region 1 quasispecies and CD81 hepatocyte expression in hepatocellular carcinoma and adjacent non-cancerous liver.
    Young KC; Lin PW; Hsiao WC; Chang TT; Chang YC; Wu HL
    J Med Virol; 2002 Oct; 68(2):188-96. PubMed ID: 12210407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral hepatitis, inflammation, and cancer: A lesson for autoimmunity.
    Piconese S; Cammarata I; Barnaba V
    J Autoimmun; 2018 Dec; 95():58-68. PubMed ID: 30509387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus as a causative agent of hepatocellular carcinoma.
    Shimotohno K
    Intervirology; 1995; 38(3-4):162-9. PubMed ID: 8682611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.